Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | . | | | 76 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | AP3B1 CL E G H | 8546 | 566 | OMIM:608233 | Hermansky-Pudlak syndrome 2 | | | | 83 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | BLOC1S3 CL E G H | 388552 | 20914 | OMIM:614077 | Hermansky-Pudlak syndrome 8 | . | | | 42 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | CALR CL E G H | 811 | 1455 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 1 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | CISD2 CL E G H | 493856 | 24212 | OMIM:604928 | Wolfram syndrome 2 | | | | 3 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | DTNBP1 CL E G H | 84062 | 17328 | OMIM:614076 | Hermansky-Pudlak syndrome 7 | . | | | 46 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | EPHB2 CL E G H | 2048 | 3393 | OMIM:618462 | Bleeding disorder, platelet-type, 22 | | | | 7 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | FLI1 CL E G H | 2313 | 3749 | OMIM:617443 | Bleeding disorder, platelet-type, 21 | . | | | 8 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GATA1 CL E G H | 2623 | 4170 | OMIM:300835 | Anemia, X-linked, with or without neutropenia and/or platelet abnormalities | HP:0040283 - Occasional | | | 29 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | HPS3 CL E G H | 84343 | 15597 | OMIM:614072 | Hermansky-Pudlak syndrome 3 | | | | 67 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | | | | 105 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | IKZF5 CL E G H | 64376 | 14283 | OMIM:619130 | THROMBOCYTOPENIA 7; THC7 | | | | | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | . | | | 69 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | . | | | 69 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619271 | BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24 | | | | 80 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | | | | 80 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | KCNJ1 CL E G H | 3758 | 6255 | OMIM:241200 | Bartter syndrome, antenatal, type 2 | . | | | 51 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | MGAT2 CL E G H | 4247 | 7045 | ORPHA:79329 | MGAT2-CDG | HP:0040283 - Occasional | | | 39 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | | | | 127 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | PLA2G4A CL E G H | 5321 | 9035 | OMIM:618372 | GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP | | | | 2 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | PLAU CL E G H | 5328 | 9052 | OMIM:601709 | Quebec platelet disorder | | | | 50 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | RASGRP2 CL E G H | 10235 | 9879 | OMIM:615888 | Bleeding disorder, platelet-type, 18 | . | | | 11 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | RUNX1 CL E G H | 861 | 10471 | OMIM:601399 | Platelet disorder, familial, with associated myeloid malignancy | | | | 181 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | SH2B3 CL E G H | 10019 | 29605 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 4 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | THPO CL E G H | 7066 | 11795 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 23 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | VWF CL E G H | 7450 | 12726 | OMIM:193400 | Von willebrand disease, type 1 | . | | | 533 | | |
HP:0003540 | HP:0003540 | Impaired platelet aggregation | 0 | VWF CL E G H | 7450 | 12726 | OMIM:277480 | Von willebrand disease, type 3 | . | | | 533 | | |
HP:0003540 | HP:0031130 | Impaired calcium ionophore-induced platelet aggregation | 1 | CL E G H | | | | | | | | | | |
HP:0003540 | HP:0031129 | Impaired phorbol myristate acetate-induced platelet aggregation | 1 | CL E G H | | | | | | | | | | |
HP:0003540 | HP:0031128 | Impaired collagen-related peptide-induced platelet aggregation | 1 | CL E G H | | | | | | | | | | |
HP:0003540 | HP:0031127 | Impaired convulxin-induced platelet aggregation | 1 | CL E G H | | | | | | | | | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | AP3B1 CL E G H | 8546 | 566 | OMIM:608233 | Hermansky-Pudlak syndrome 2 | | | | 83 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | CALR CL E G H | 811 | 1455 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 1 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | CALR CL E G H | 811 | 1455 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 1 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | CALR CL E G H | 811 | 1455 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 1 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | CISD2 CL E G H | 493856 | 24212 | OMIM:604928 | Wolfram syndrome 2 | | | | 3 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | FLI1 CL E G H | 2313 | 3749 | OMIM:617443 | Bleeding disorder, platelet-type, 21 | | | | 8 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040280 - Obligate | | | 23 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040280 - Obligate | | | 8 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040280 - Obligate | | | 21 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | | | | 105 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | . | | | 45 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | IKZF5 CL E G H | 64376 | 14283 | OMIM:619130 | THROMBOCYTOPENIA 7; THC7 | | | | | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | IKZF5 CL E G H | 64376 | 14283 | OMIM:619130 | THROMBOCYTOPENIA 7; THC7 | | | | | | |
HP:0003540 | HP:0011870 | Impaired arachidonic acid-induced platelet aggregation | 1 | IKZF5 CL E G H | 64376 | 14283 | OMIM:619130 | THROMBOCYTOPENIA 7; THC7 | | | | | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | IKZF5 CL E G H | 64376 | 14283 | OMIM:619130 | THROMBOCYTOPENIA 7; THC7 | | | | | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040284 - Very rare | | | 69 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619271 | BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24 | | | | 80 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619271 | BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24 | | | | 80 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619271 | BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24 | | | | 80 | | |
HP:0003540 | HP:0011870 | Impaired arachidonic acid-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619271 | BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24 | | | | 80 | | |
HP:0003540 | HP:0011871 | Impaired ristocetin-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040284 - Very rare | | | 80 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | . | | | 127 | | |
HP:0003540 | HP:0011872 | Impaired thrombin-induced platelet aggregation | 1 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | . | | | 127 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | PLAU CL E G H | 5328 | 9052 | OMIM:601709 | Quebec platelet disorder | . | | | 50 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | SH2B3 CL E G H | 10019 | 29605 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 4 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | SH2B3 CL E G H | 10019 | 29605 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 4 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | SH2B3 CL E G H | 10019 | 29605 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 4 | | |
HP:0003540 | HP:0011894 | Impaired thromboxane A2 agonist-induced platelet aggregation | 1 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0003540 | HP:0008148 | Impaired epinephrine-induced platelet aggregation | 1 | THPO CL E G H | 7066 | 11795 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 23 | | |
HP:0003540 | HP:0004866 | Impaired ADP-induced platelet aggregation | 1 | THPO CL E G H | 7066 | 11795 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 23 | | |
HP:0003540 | HP:0008320 | Impaired collagen-induced platelet aggregation | 1 | THPO CL E G H | 7066 | 11795 | OMIM:187950 | THROMBOCYTHEMIA 1; THCYT1 | | | | 23 | | |